Adherence and identification of access barriers in patients with autoimmune diseases treated with an adalimumab biosimilar in Colombia. Univ. Sci. [Internet]. 2025 Oct. 29 [cited 2025 Nov. 1];:S17. Available from: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41507